Chinese General Practice ›› 2020, Vol. 23 ›› Issue (2): 125-129.DOI: 10.12114/j.issn.1007-9572.2019.00.262
• Monographic Research • Next Articles
Published:
2020-01-15
Online:
2020-01-15
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.262
[1]陈建,杨晓虹,曾莉萍,等.成都新都区社区居民老年慢性病患病现状及其患共病模式分析[J].中国卫生事业管理,2018,35(8):573-575,615. [2]GUTHRIE B,MAKUBATE B,HERNANDEZ-SANTIAGO V,et al.The rising tide of polypharmacy and drug-drug interactions:population database analysis 1995—2010[J].BMC Med,2015,13:74.DOI:10.1186/s12916-015-0322-7. [3]UK N M A P.Medicines optimisation:the safe and effective use of medicines to enable the best possible outcomes[M].Manchester:National Institute for Health and Care Excellence (UK),2015. [4]YOUSSEF A.Pharmaceutical care practice:the clinician's guide[J].Int J Toxicol,2004,23(6):379-380.DOI:10.1080/10915810490902074. [5]ETON D T,RIDGEWAY J L,EGGINTON J S,et al.Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions[J].Patient Relat Outcome Meas,2015,6:117-126.DOI:10.2147/PROM.S78955. [6]SAV A,SALEHI A,MAIR F S,et al.Measuring the burden of treatment for chronic disease:implications of a scoping review of the literature[J].BMC Med Res Methodol,2017,17(1):140.DOI:10.1186/s12874-017-0411-8. [7]BOYCE M B,BROWNE J P,GREENHALGH J.The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare:a systematic review of qualitative research[J].BMJ Qual Saf,2014,23(6):508-518.DOI:10.1136/bmjqs-2013-002524. [8]MOHAMMED M A,MOLES R J,CHEN T F.Medication-related burden and patients' lived experience with medicine:a systematic review and metasynthesis of qualitative studies[J].BMJ Open,2016,6(2):e010035.DOI:10.1136/bmjopen-2015-010035. [9]ATKINSON M J,SINHA A,HASS S L,et al.Validation of a general measure of treatment satisfaction,the Treatment Satisfaction Questionnaire for Medication (TSQM),using a national panel study of chronic disease[J].Health Qual Life Outcomes,2004,2:12.DOI:10.1186/1477-7525-2-12. [10]ATKINSON M J,KUMAR R,CAPPELLERI J C,et al.Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM versionⅡ) among outpatient pharmacy consumers[J].Value Health,2005,8(Suppl 1):S9-24.DOI:10.1111/j.1524-4733.2005.00066.x. [11]BHARMAL M,PAYNE K,ATKINSON M J,et al.Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications[J].Health Qual Life Outcomes,2009,7:36.DOI:10.1186/1477-7525-7-36. [12]ZANICHELLI A,AZIN G M,CRISTINA F,et al.Safety,effectiveness,and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert?) in patients with hereditary angioedema:the SABHA study[J].Orphanet J Rare Dis,2018,13(1):51.DOI:10.1186/s13023-018-0797-3. [13]尚雅彬,刘红霞,于立新,等.药物治疗满意度量表的跨文化调试及其在肾移植受者中应用的信度效度检验[J].中国护理管理,2018,18(5):612-616.DOI:10.3969/j.issn.1672-1756.2018.05.008. [14]VAN DEN BOSCH F,OSTOR A J K,WASSENBERG S,et al. Impact of participation in the adalimumab (humira) patient support program on rheumatoid arthritis treatment course:results from the PASSION study[J].Rheumatol Ther,2017,4(1):85-96.DOI:10.1007/s40744-017-0061-7. [15]ZYOUD S H,AL-JABI S W,SWEILEH W M,et al.Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus:findings from a cross-sectional study[J].J Clin Transl Endocrinol,2015,2(2):66-71.DOI:10.1016/j.jcte.2015.03.002. [16]RUIZ M A,PARDO A,REJAS J,et al.Development and validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)[J].Value Health,2008,11(5):913-926.DOI:10.1111/j.1524-4733.2008.00323.x. [17]REJAS J,RUIZ M,PARDO A,et al.Detecting changes in patient treatment satisfaction with medicines:the SATMED-Q[J].Value Health,2013,16(1):88-96.DOI:10.1016/j.jval.2012.08.2224. [18]QUINLAN P,MAGID S K,O’FLAHERTY D,et al.Patient satisfaction with medication management[J].J Nurs Care Qual,2007,22(1):34-39.DOI:10.1097/00001786-200701000-00008. [19]HORNE R,HANKINS M,JENKINS R.The Satisfaction with Information about Medicines Scale (SIMS):a new measurement tool for audit and research[J].Qual Health Care,2001,10(3):135-140. [20]BOONS C C L M,TIMMERS L,VAN SCHOOR N M,et al.Patient satisfaction with information on oral anticancer agent use[J].Cancer Med,2018,7(1):219-228.DOI:10.1002/cam4.1239. [21]NOTA I,DROSSAERT C H,TAAL E,et al.Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs[J].Arthritis Res Ther,2016,18(1):252.DOI:10.1186/s13075-016-1138-3. [22]DREVENHORN E,BENGTSON A,NYBERG P,et al.Effects on hypertensive patients' satisfaction with information about their medication after nurses' consultation training[J].Pragmat Obs Res,2011,5:35-41.DOI:10.2147/POR.S58352. [23]BOONS C C L M,TIMMERS L,VAN SCHOOR N M,et al.Patient satisfaction with information on oral anticancer agent use[J].Cancer Med,2018,7(1):219-228.DOI:10.1002/cam4.1239. [24]KRSKA J,MORECROFT C W,ROWE P H,et al.Measuring the impact of long-term medicines use from the patient perspective[J].Int J Clin Pharm,2014,36(4):675-678.DOI:10.1007/s11096-014-9970-5. [25]KRSKA J,KATUSIIME B,CORLETT S A.Validation of an instrument to measure patients' experiences of medicine use:the Living with Medicines Questionnaire[J].Patient Prefer Adherence,2017,11:671-679.DOI:10.2147/PPA.S126647. [26]KATUSIIME B,CORLETT S A,KRSKA J.Development and validation of a revised instrument to measure burden of long-term medicines use:the Living with Medicines Questionnaire version 3[J].Patient Relat Outcome Meas,2018,9:155-168.DOI:10.2147/PROM.S151143. [27]ZIDAN A,AWAISU A,HASAN S,et al.The living with medicines questionnaire:translation and cultural adaptation into the Arabic context[J].Value Health Reg Issues,2016,10:36-40.DOI:10.1016/j.vhri.2016.07.001. [28]CARTER S R,BULANADI M G,KATUSIIME B,et al.Comprehensibly measuring patients' subjective thoughts,feelings and experiences of living with medicines:the Living with Medicines Questionnaire (LMQ)[J].Int J Clin Pharm,2015,37(2):424-425. [29]MOHAMMED M A,MOLES R J,HILMER S N,et al.Development and validation of an instrument for measuring the burden of medicine on functioning and well-being:the Medication-Related Burden Quality of Life (MRB-QoL) tool[J].BMJ Open,2018,8(1):e018880.DOI:10.1136/bmjopen-2017-018880. [30]SAKTHONG P,SUKSANGA P,SAKULBUMRUNGSIL R,et al.Development of Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL):a novel instrument for medication management[J].Res Social Adm Pharm,2015,11(3):315-338.DOI:10.1016/j.sapharm.2014.10.002. [31]REEVE E,SHAKIB S,HENDRIX I,et al.Development and validation of the Patients' Attitudes Towards Deprescribing (PATD) questionnaire[J].Int J Clin Pharm,2013,35(1):51-56.DOI:10.1007/s11096-012-9704-5. [32]REEVE E,LOW L F,SHAKIB S,et al.Development and validation of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire:versions for older adults and caregivers[J].Drugs Aging,2016,33(12):913-928.DOI:10.1007/s40266-016-0410-1. [33]吴慧利.老年住院糖尿病患者潜在不恰当用药现状及停药态度问卷的适用性研究[D].郑州:郑州大学,2017. [34]SCHI?TZ M L,FR?LICH A,JENSEN A K,et al.Polypharmacy and medication deprescribing:a survey among multimorbid older adults in Denmark[J].Pharmacol Res Perspect,2018,6(6):e00431.DOI:10.1002/prp2.431. |
[1] | WEI Mengyu, WANG Jiajia, ZHANG Yingying, LI Chunyang, LI Jiansheng. Research Status of Patient-reported Outcome Assessment Tools for Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3725-3733. |
[2] | WANG Xinyuan, WANG Xiaolei, LIU Yanli, AN Ran, LUO Jiao, LIU Xiaofei, LI Yangyang, HU Chongdie, HOU Fuwen. Advances in Evaluation Tools for Resistiveness to Care in Patients with Dementia [J]. Chinese General Practice, 2023, 26(22): 2816-2822. |
[3] | WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan. Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease [J]. Chinese General Practice, 2023, 26(17): 2155-2161. |
[4] | Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) [J]. Chinese General Practice, 2023, 26(14): 1671-1691. |
[5] | YAO Huijuan, YANG Yu, XU Ajing. Interpretation of Diabetes Management in Chronic Kidney Disease: a Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) [J]. Chinese General Practice, 2023, 26(12): 1415-1421. |
[6] | WANG Tong, QUAN Haishan, TIAN Bowen, LI Ying, CUI Qianqian, LIU Yao, ZHU Huahua. Fatigue in Chronic Obstructive Pulmonary Disease: a Scoping Review [J]. Chinese General Practice, 2023, 26(07): 893-902. |
[7] | SONG Pingan, CHEN Xiaoliang, YAO Yuan, GAO Jin, YANG Yang, CUI Hongchun, ZHANG Yi. Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(02): 241-247. |
[8] | MA Haiqi, ZHAI Huimin, BU Mengru. Recent Advances in Assessment Tools for HIV/AIDS-related Psychological Distress [J]. Chinese General Practice, 2022, 25(35): 4473-4478. |
[9] | LIU Songyi, MENG Wenqi, PENG Haibo, JIANG Xiaoli, LI Zixin, YU Qianqian, YIN Wenqiang, CHEN Zhongming, SUN Kui, GUO Hongwei. Contracted Residents' Evaluation for Continuity of Contracted Family Doctor Services and Influencing Factors [J]. Chinese General Practice, 2022, 25(34): 4312-4317. |
[10] | YANG Shuang, HU Aiping, XIANG Mingfang. Research Progress on Assessment Tools of Intimate Partner Violence [J]. Chinese General Practice, 2022, 25(31): 3965-3970. |
[11] | FU Qiangqiang, JIN Hua, LI Li, MA Yu, YU Dehua. Research Status of Health Literacy Assessment Tools from the Perspective of Active Health and Its Enlightenment to China [J]. Chinese General Practice, 2022, 25(31): 3933-3943. |
[12] | Pengxiang ZHANG, Lin ZENG, Lu MENG, Qian HUANG, Gaoxiang WANG, Deliang LIU. New Research Progress of the Novel Target Drugs for the Treatment of Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2022, 25(20): 2551-2557. |
[13] | Jindan ZHANG, Xiaofan CHEN, Xiuhua MAO, Chenxi WANG, Xinting LIANG, Lu ZHANG, Aiyun CHEN. Quality of Primary Care Services: a Perspective from Chronic Disease Patients [J]. Chinese General Practice, 2022, 25(19): 2391-2398. |
[14] | Ling LI, Huijuan ZHANG. Recent Developments in Pituitary-directed Medical Treatment for Cushing's Disease [J]. Chinese General Practice, 2022, 25(14): 1789-1794. |
[15] |
CHEN Xiaofeng, WANG Meng, LI Zhongyu, LI Jiajia.
Clinical Study of Venetoclax with Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia [J]. Chinese General Practice, 2022, 25(08): 957-962. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||